30 likes | 33 Views
China tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.1% during the forecast period. China being the largest populated country has the worldu2019s second largest burden of multidrug-resistant tuberculosis. Government initiatives play an important role in market growth as they are responsible for large adoption of tuberculosis diagnosis and treatment.
E N D
Orion Market Research China Tuberculosis Diagnosis and Treatment Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our China Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/china-tuberculosis-diagnosis-treatment-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404
China tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.1% during the forecast period. China being the largest populated country has the world’s second largest burden of multidrug-resistant tuberculosis. Government initiatives play an important role in market growth as they are responsible for large adoption of tuberculosis diagnosis and treatment. China launched the 10 year Infectious and Endemic Disease Control (IEDC) project in 1991 to curb the TB epidemic in 13 of its 31 mainland provinces. It was funded by a World Bank loan of $58 million and this project adopted the TB DOTS strategy as well as short course drug treatment developed by the World Health Organization (WHO) in 1989. The project set out to improve the finding of new smear positive cases from 35% to 70%. A full Report of China Tuberculosis Diagnosis and Treatment Market is Available at: https://www.omrglobal.com/industry-reports/china-tuberculosis-diagnosis-treatment-market China tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing. Request a Free Sample of our China Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/china-tuberculosis-diagnosis-treatment-market China Tuberculosis Diagnosis and Treatment Market Segmentation By Drugs Type •First Line Drugs •Second Line Drugs By Diagnosis •Laboratory Testing •Nucleic Acid Amplification Test •Mantoux Test •Radiography •Drug Susceptibility Testing Company Profiles •Abbott Laboratories •Becton, Dickinson and Co. •Biochemical and Synthetic Products Pvt Ltd. •Eiken Chemical Co., Ltd. •F. Hoffmann-La Roche Ltd.
•GlaxoSmithKline PLC •Labatec Pharma SA •Lupin Pharmaceuticals, Inc. •Thermo Fisher Scientific For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/china-tuberculosis-diagnosis-treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404